FIELD: medicine.
SUBSTANCE: invention refers to chemical pharmaceutical industry and concerns production of pharmaceutical composition of hypolipidemic and hepatoprotective activity. Composition contains statine or its pharmaceutically active salt, phospholipid of both vegetative and animal origin at total statine and phospholipid content 34-91.1 mass % and proportion 1:3 to 1:100, and base.
EFFECT: composition in various medicinal forms is characterised high efficiency, low by-effects, high hypolipidemic and hepatoprotective activity, thus allows treatment of active liver disease.
14 cl, 138 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION WITH HEPATOPROTECTIVE AND METABOLISM NORMALIZING ACTIVITY | 2005 |
|
RU2283114C1 |
PHARMACEUTICAL COMPOSITIONS BASED ON 9-BUTYLAMINO-3,3-DIMETHYL-3,4-DIHYDROACRIDINE-1(2H)-ONE HYDROCHLORIDE FOR THE CORRECTION OF COGNITIVE AND NEUROLOGICAL DISORDERS | 2015 |
|
RU2664439C2 |
PHARMACEUTICAL COMPOSITION OF STATINS WITH PREBIOTIC FOR THERAPY OF HYPERCHOLESTEREMIA AND HYPERLIPIDEMIA | 2014 |
|
RU2591079C2 |
SOLID DOSAGE FORM HAVING HYPOLIPIDEMIC AND HYPOCHOLESTEREMIC ACTIVITY, AND METHOD OF ITS PRODUCTION | 2009 |
|
RU2404767C1 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
ANTI-INFLAMMATORY MEDICINAL AGENT | 2005 |
|
RU2283112C1 |
AGENT FOR TREATMENT OF PROSTATE DISEASE | 2005 |
|
RU2278681C1 |
TREATMENT-AND-PREVENTIVE AGENT OF ANTIBACTERIAL AND SPERMICIDAL ACTION | 2006 |
|
RU2329790C1 |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDEMIA | 2017 |
|
RU2683641C2 |
PHARMACEUTICAL COMPOSITION FOR HYPERLIPIDEMIA TREATMENT | 2014 |
|
RU2623876C2 |
Authors
Dates
2008-07-20—Published
2007-04-02—Filed